Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine

被引:30
作者
Paunio, M
Peltola, H
Valle, M
Davidkin, I
Virtanen, M
Heinonen, OP
机构
[1] Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Childrens Hosp, FIN-00014 Helsinki, Finland
[3] Natl Publ Hlth Inst, Helsinki, Finland
[4] Natl Res & Dev Ctr Welf & Hlth, Helsinki, Finland
关键词
D O I
10.1136/jech.53.3.173
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective-To study measles risk after revaccination. Design-A population-based case-control study during an epidemic season. Main outcome measure-Relative serologically confirmed measles risk. Participants and methods-153 vaccinated cases, mostly from rural areas, were serologically confirmed as measles at the central laboratory in 1988-89. A randomly selected group of 453 controls from either municipalities of vaccinated cases or from areas where measles attack rate was >600/105, was identified via the population registry. Vaccination and measles histories of cases and controls were determined from official vaccination cards. Results-Once and twice vaccinated had crude relative risk 15.6 and 2.3 compared with thrice vaccinated. When cases who had received their first vaccination at less than 14 months of age were omitted from analysis, once vaccinated had 4.0 (95% CI 1.2, 16.6) times higher age adjusted measles risk compared with twice vaccinated. When, omission was extended to cases from one particular municipality where even revaccinees had high measles risk during an explosive outbreak the corresponding risk ratio was 17.8 (2.8, 67.8). Conclusions-Twice vaccinated have better protection against epidemic measles compared with single dose recipients.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 67 条
  • [1] VACCINATED CHILDREN GET MILDER MEASLES INFECTION - A COMMUNITY STUDY FROM GUINEA-BISSAU
    AABY, P
    BUKH, J
    LEERHOY, J
    LISSE, IM
    MORDHORST, CH
    PEDERSEN, IR
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (05) : 858 - 863
  • [2] THE 1988-1989 MEASLES EPIDEMIC IN HUNGARY - ASSESSMENT OF VACCINE FAILURE
    AGOCS, MM
    MARKOWITZ, LE
    STRAUB, I
    DOMOK, I
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1992, 21 (05) : 1007 - 1013
  • [3] DIRECTLY TRANSMITTED INFECTIOUS-DISEASES - CONTROL BY VACCINATION
    ANDERSON, RM
    MAY, RM
    [J]. SCIENCE, 1982, 215 (4536) : 1053 - 1060
  • [4] ANDRE FE, 1983, REV INFECT DIS, V5, P532
  • [5] BIN D, 1991, B WORLD HEALTH ORGAN, V69, P415
  • [6] MEASLES, MUMPS, AND RUBELLA ANTIBODIES IN CHILDREN 5-6 YEARS AFTER IMMUNIZATION - EFFECT OF VACCINE TYPE AND AGE AT VACCINATION
    BOULIANNE, N
    DESERRES, G
    RATNAM, S
    WARD, BJ
    JOLY, JR
    DUVAL, B
    [J]. VACCINE, 1995, 13 (16) : 1611 - 1616
  • [7] PERSISTENCE OF MEASLES ANTIBODY IN ABSENCE OF CIRCULATING NATURAL VIRUS 5 YEARS AFTER IMMUNIZATION OF AN ISOLATED VIRGIN POPULATION WITH EDMONSTON-B VACCINE
    BROWN, P
    GAJDUSEK, DC
    TSAI, T
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 90 (06) : 514 - &
  • [8] ANTIBODY-RESPONSE FOLLOWING MEASLES-MUMPS-RUBELLA VACCINE UNDER CONDITIONS OF CUSTOMARY USE
    BRUNELL, PA
    WEIGLE, K
    MURPHY, MD
    SHEHAB, Z
    COBB, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (11): : 1409 - 1412
  • [9] Centers for Disease Control and Prevention, 1984, MMWR-MORBID MORTAL W, V33, P349
  • [10] MEASLES ANTIBODY - REEVALUATION OF PROTECTIVE TITERS
    CHEN, RT
    MARKOWITZ, LE
    ALBRECHT, P
    STEWART, JA
    MOFENSON, LM
    PREBLUD, SR
    ORENSTEIN, WA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (05) : 1036 - 1042